nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC6A3—Parkinson's disease	0.155	0.208	CbGaD
Desipramine—HTR1A—Parkinson's disease	0.136	0.182	CbGaD
Desipramine—DRD2—Parkinson's disease	0.116	0.155	CbGaD
Desipramine—CYP2E1—Parkinson's disease	0.111	0.149	CbGaD
Desipramine—HTR2A—Parkinson's disease	0.0893	0.119	CbGaD
Desipramine—CYP2D6—Parkinson's disease	0.0817	0.109	CbGaD
Desipramine—ABCB1—Parkinson's disease	0.0583	0.078	CbGaD
Desipramine—SLC6A2—locus ceruleus—Parkinson's disease	0.00341	0.0398	CbGeAlD
Desipramine—HTR2A—enteric nervous system—Parkinson's disease	0.00311	0.0362	CbGeAlD
Desipramine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.0027	0.0314	CbGeAlD
Desipramine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00235	0.0274	CbGeAlD
Desipramine—HTR2A—locus ceruleus—Parkinson's disease	0.00205	0.0239	CbGeAlD
Desipramine—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00201	0.0234	CbGeAlD
Desipramine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00194	0.0226	CbGeAlD
Desipramine—SLC6A2—autonomic nervous system—Parkinson's disease	0.00181	0.0211	CbGeAlD
Desipramine—HTR2A—cerebellar cortex—Parkinson's disease	0.00167	0.0195	CbGeAlD
Desipramine—HTR1A—telencephalic ventricle—Parkinson's disease	0.00163	0.019	CbGeAlD
Desipramine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00162	0.0189	CbGeAlD
Desipramine—DRD2—telencephalic ventricle—Parkinson's disease	0.00147	0.0172	CbGeAlD
Desipramine—SLC6A3—nerve—Parkinson's disease	0.00126	0.0147	CbGeAlD
Desipramine—HTR2A—pons—Parkinson's disease	0.00118	0.0138	CbGeAlD
Desipramine—SLC22A3—tongue—Parkinson's disease	0.00116	0.0136	CbGeAlD
Desipramine—SMPD1—forebrain—Parkinson's disease	0.00115	0.0134	CbGeAlD
Desipramine—HTR2A—autonomic nervous system—Parkinson's disease	0.00109	0.0127	CbGeAlD
Desipramine—SLC6A2—nerve—Parkinson's disease	0.00102	0.0119	CbGeAlD
Desipramine—HTR2A—telencephalic ventricle—Parkinson's disease	0.000973	0.0113	CbGeAlD
Desipramine—SMPD1—cardiovascular system—Parkinson's disease	0.000973	0.0113	CbGeAlD
Desipramine—SLC6A3—hindbrain—Parkinson's disease	0.000947	0.011	CbGeAlD
Desipramine—DRD2—nerve—Parkinson's disease	0.000929	0.0108	CbGeAlD
Desipramine—SLC6A4—hindbrain—Parkinson's disease	0.000868	0.0101	CbGeAlD
Desipramine—HTR2A—peripheral nervous system—Parkinson's disease	0.000786	0.00917	CbGeAlD
Desipramine—HTR1A—hindbrain—Parkinson's disease	0.00077	0.00898	CbGeAlD
Desipramine—SMPD1—spinal cord—Parkinson's disease	0.000741	0.00864	CbGeAlD
Desipramine—DRD2—hindbrain—Parkinson's disease	0.000696	0.00811	CbGeAlD
Desipramine—SMPD1—head—Parkinson's disease	0.000659	0.00768	CbGeAlD
Desipramine—SMPD1—nervous system—Parkinson's disease	0.000624	0.00728	CbGeAlD
Desipramine—HTR2A—nerve—Parkinson's disease	0.000613	0.00715	CbGeAlD
Desipramine—SMPD1—central nervous system—Parkinson's disease	0.000601	0.00701	CbGeAlD
Desipramine—SMPD1—cerebellum—Parkinson's disease	0.000588	0.00685	CbGeAlD
Desipramine—CHRM4—head—Parkinson's disease	0.000561	0.00653	CbGeAlD
Desipramine—SLC22A3—embryo—Parkinson's disease	0.000558	0.0065	CbGeAlD
Desipramine—SLC6A3—brainstem—Parkinson's disease	0.000543	0.00633	CbGeAlD
Desipramine—CHRM4—nervous system—Parkinson's disease	0.000532	0.0062	CbGeAlD
Desipramine—CHRM2—forebrain—Parkinson's disease	0.000525	0.00612	CbGeAlD
Desipramine—HTR2C—brainstem—Parkinson's disease	0.000525	0.00611	CbGeAlD
Desipramine—SLC6A3—forebrain—Parkinson's disease	0.000524	0.0061	CbGeAlD
Desipramine—SLC22A1—forebrain—Parkinson's disease	0.000516	0.00601	CbGeAlD
Desipramine—CHRM4—central nervous system—Parkinson's disease	0.000512	0.00596	CbGeAlD
Desipramine—HTR2C—forebrain—Parkinson's disease	0.000506	0.0059	CbGeAlD
Desipramine—SLC6A4—brainstem—Parkinson's disease	0.000497	0.0058	CbGeAlD
Desipramine—ADRB1—forebrain—Parkinson's disease	0.000497	0.00579	CbGeAlD
Desipramine—SLC6A4—forebrain—Parkinson's disease	0.00048	0.00559	CbGeAlD
Desipramine—CHRM1—forebrain—Parkinson's disease	0.000478	0.00557	CbGeAlD
Desipramine—SMPD1—brain—Parkinson's disease	0.000477	0.00556	CbGeAlD
Desipramine—HTR2A—hindbrain—Parkinson's disease	0.000459	0.00535	CbGeAlD
Desipramine—CHRM2—cardiovascular system—Parkinson's disease	0.000444	0.00518	CbGeAlD
Desipramine—HTR1A—brainstem—Parkinson's disease	0.000442	0.00515	CbGeAlD
Desipramine—CHRM5—head—Parkinson's disease	0.000438	0.00511	CbGeAlD
Desipramine—SLC6A2—brainstem—Parkinson's disease	0.000438	0.0051	CbGeAlD
Desipramine—CHRM3—forebrain—Parkinson's disease	0.000428	0.00499	CbGeAlD
Desipramine—HTR1A—forebrain—Parkinson's disease	0.000426	0.00497	CbGeAlD
Desipramine—SLC6A2—forebrain—Parkinson's disease	0.000423	0.00493	CbGeAlD
Desipramine—ADRB1—cardiovascular system—Parkinson's disease	0.00042	0.0049	CbGeAlD
Desipramine—CYP2D6—hindbrain—Parkinson's disease	0.000418	0.00488	CbGeAlD
Desipramine—CHRM5—nervous system—Parkinson's disease	0.000415	0.00484	CbGeAlD
Desipramine—CHRM4—brain—Parkinson's disease	0.000406	0.00474	CbGeAlD
Desipramine—CHRM1—cardiovascular system—Parkinson's disease	0.000404	0.00471	CbGeAlD
Desipramine—CHRM5—central nervous system—Parkinson's disease	0.0004	0.00466	CbGeAlD
Desipramine—DRD2—brainstem—Parkinson's disease	0.000399	0.00465	CbGeAlD
Desipramine—DRD2—forebrain—Parkinson's disease	0.000385	0.00449	CbGeAlD
Desipramine—HTR2C—medulla oblongata—Parkinson's disease	0.000366	0.00426	CbGeAlD
Desipramine—ORM1—spinal cord—Parkinson's disease	0.000363	0.00423	CbGeAlD
Desipramine—HTR1A—cardiovascular system—Parkinson's disease	0.00036	0.0042	CbGeAlD
Desipramine—SLC22A4—spinal cord—Parkinson's disease	0.000349	0.00407	CbGeAlD
Desipramine—SLC6A3—midbrain—Parkinson's disease	0.000346	0.00403	CbGeAlD
Desipramine—SLC6A3—spinal cord—Parkinson's disease	0.000337	0.00393	CbGeAlD
Desipramine—HTR2C—midbrain—Parkinson's disease	0.000334	0.0039	CbGeAlD
Desipramine—HTR2C—spinal cord—Parkinson's disease	0.000326	0.0038	CbGeAlD
Desipramine—CHRM5—brain—Parkinson's disease	0.000318	0.0037	CbGeAlD
Desipramine—SLC6A4—midbrain—Parkinson's disease	0.000317	0.00369	CbGeAlD
Desipramine—CYP2A6—cerebellum—Parkinson's disease	0.000316	0.00368	CbGeAlD
Desipramine—SLC6A4—spinal cord—Parkinson's disease	0.000309	0.0036	CbGeAlD
Desipramine—ORM1—nervous system—Parkinson's disease	0.000306	0.00356	CbGeAlD
Desipramine—SLC6A2—medulla oblongata—Parkinson's disease	0.000305	0.00356	CbGeAlD
Desipramine—HRH1—forebrain—Parkinson's disease	0.000304	0.00354	CbGeAlD
Desipramine—CHRM2—head—Parkinson's disease	0.000301	0.00351	CbGeAlD
Desipramine—SLC6A3—head—Parkinson's disease	0.0003	0.0035	CbGeAlD
Desipramine—SLC22A1—head—Parkinson's disease	0.000295	0.00344	CbGeAlD
Desipramine—ORM1—central nervous system—Parkinson's disease	0.000294	0.00343	CbGeAlD
Desipramine—HTR2C—head—Parkinson's disease	0.00029	0.00338	CbGeAlD
Desipramine—HTR2A—embryo—Parkinson's disease	0.000287	0.00335	CbGeAlD
Desipramine—Benazepril—MTHFR—Parkinson's disease	0.000287	0.0396	CrCbGaD
Desipramine—CHRM2—nervous system—Parkinson's disease	0.000285	0.00332	CbGeAlD
Desipramine—ADRB1—head—Parkinson's disease	0.000284	0.00332	CbGeAlD
Desipramine—SLC6A3—nervous system—Parkinson's disease	0.000284	0.00331	CbGeAlD
Desipramine—SLC22A3—head—Parkinson's disease	0.000282	0.00329	CbGeAlD
Desipramine—HTR1A—midbrain—Parkinson's disease	0.000281	0.00328	CbGeAlD
Desipramine—SLC22A1—nervous system—Parkinson's disease	0.00028	0.00326	CbGeAlD
Desipramine—SLC22A4—cerebellum—Parkinson's disease	0.000277	0.00323	CbGeAlD
Desipramine—HTR2C—nervous system—Parkinson's disease	0.000275	0.0032	CbGeAlD
Desipramine—SLC6A4—head—Parkinson's disease	0.000275	0.0032	CbGeAlD
Desipramine—HTR1A—spinal cord—Parkinson's disease	0.000275	0.0032	CbGeAlD
Desipramine—CHRM2—central nervous system—Parkinson's disease	0.000275	0.0032	CbGeAlD
Desipramine—CHRM1—head—Parkinson's disease	0.000274	0.00319	CbGeAlD
Desipramine—SLC6A3—central nervous system—Parkinson's disease	0.000274	0.00319	CbGeAlD
Desipramine—ADRB1—nervous system—Parkinson's disease	0.00027	0.00314	CbGeAlD
Desipramine—SLC22A1—central nervous system—Parkinson's disease	0.00027	0.00314	CbGeAlD
Desipramine—SLC22A3—nervous system—Parkinson's disease	0.000268	0.00312	CbGeAlD
Desipramine—SLC6A3—cerebellum—Parkinson's disease	0.000268	0.00312	CbGeAlD
Desipramine—HTR2C—central nervous system—Parkinson's disease	0.000265	0.00308	CbGeAlD
Desipramine—CYP2B6—cardiovascular system—Parkinson's disease	0.000263	0.00307	CbGeAlD
Desipramine—HTR2A—brainstem—Parkinson's disease	0.000263	0.00307	CbGeAlD
Desipramine—SLC6A4—nervous system—Parkinson's disease	0.000261	0.00304	CbGeAlD
Desipramine—ADRB1—central nervous system—Parkinson's disease	0.00026	0.00303	CbGeAlD
Desipramine—CHRM1—nervous system—Parkinson's disease	0.00026	0.00303	CbGeAlD
Desipramine—SLC22A5—medulla oblongata—Parkinson's disease	0.000259	0.00302	CbGeAlD
Desipramine—SLC22A3—central nervous system—Parkinson's disease	0.000258	0.003	CbGeAlD
Desipramine—CYP2A6—brain—Parkinson's disease	0.000257	0.00299	CbGeAlD
Desipramine—DRD2—midbrain—Parkinson's disease	0.000254	0.00296	CbGeAlD
Desipramine—HTR2A—forebrain—Parkinson's disease	0.000254	0.00296	CbGeAlD
Desipramine—SLC6A4—central nervous system—Parkinson's disease	0.000251	0.00292	CbGeAlD
Desipramine—CHRM1—central nervous system—Parkinson's disease	0.00025	0.00291	CbGeAlD
Desipramine—CYP2E1—cardiovascular system—Parkinson's disease	0.000247	0.00288	CbGeAlD
Desipramine—CHRM3—head—Parkinson's disease	0.000245	0.00286	CbGeAlD
Desipramine—HTR1A—head—Parkinson's disease	0.000244	0.00284	CbGeAlD
Desipramine—SLC6A2—head—Parkinson's disease	0.000242	0.00282	CbGeAlD
Desipramine—CYP2D6—brainstem—Parkinson's disease	0.00024	0.00279	CbGeAlD
Desipramine—SLC22A5—midbrain—Parkinson's disease	0.000237	0.00276	CbGeAlD
Desipramine—CHRM3—nervous system—Parkinson's disease	0.000232	0.00271	CbGeAlD
Desipramine—CYP2D6—forebrain—Parkinson's disease	0.000231	0.0027	CbGeAlD
Desipramine—HTR1A—nervous system—Parkinson's disease	0.000231	0.0027	CbGeAlD
Desipramine—SLC22A5—spinal cord—Parkinson's disease	0.000231	0.00269	CbGeAlD
Desipramine—Epinastine—HTR7—Parkinson's disease	0.000229	0.0317	CrCbGaD
Desipramine—SLC6A2—nervous system—Parkinson's disease	0.000229	0.00267	CbGeAlD
Desipramine—SLC22A4—brain—Parkinson's disease	0.000225	0.00262	CbGeAlD
Desipramine—CHRM3—central nervous system—Parkinson's disease	0.000224	0.00261	CbGeAlD
Desipramine—HTR1A—central nervous system—Parkinson's disease	0.000223	0.0026	CbGeAlD
Desipramine—SLC6A2—central nervous system—Parkinson's disease	0.000221	0.00257	CbGeAlD
Desipramine—DRD2—head—Parkinson's disease	0.00022	0.00257	CbGeAlD
Desipramine—CHRM2—brain—Parkinson's disease	0.000218	0.00254	CbGeAlD
Desipramine—HTR1A—cerebellum—Parkinson's disease	0.000218	0.00254	CbGeAlD
Desipramine—SLC6A3—brain—Parkinson's disease	0.000217	0.00253	CbGeAlD
Desipramine—HTR2A—cardiovascular system—Parkinson's disease	0.000215	0.0025	CbGeAlD
Desipramine—SLC22A1—brain—Parkinson's disease	0.000214	0.0025	CbGeAlD
Desipramine—CYP2E1—medulla oblongata—Parkinson's disease	0.000211	0.00246	CbGeAlD
Desipramine—HTR2C—brain—Parkinson's disease	0.00021	0.00245	CbGeAlD
Desipramine—DRD2—nervous system—Parkinson's disease	0.000209	0.00244	CbGeAlD
Desipramine—ADRB1—brain—Parkinson's disease	0.000206	0.0024	CbGeAlD
Desipramine—SLC22A3—brain—Parkinson's disease	0.000205	0.00238	CbGeAlD
Desipramine—DRD2—central nervous system—Parkinson's disease	0.000201	0.00235	CbGeAlD
Desipramine—SLC6A4—brain—Parkinson's disease	0.000199	0.00232	CbGeAlD
Desipramine—CHRM1—brain—Parkinson's disease	0.000198	0.00231	CbGeAlD
Desipramine—Maprotiline—HTR7—Parkinson's disease	0.000198	0.0273	CrCbGaD
Desipramine—DRD2—cerebellum—Parkinson's disease	0.000197	0.00229	CbGeAlD
Desipramine—CYP2E1—spinal cord—Parkinson's disease	0.000188	0.00219	CbGeAlD
Desipramine—ABCB1—embryo—Parkinson's disease	0.000188	0.00219	CbGeAlD
Desipramine—HTR2A—medulla oblongata—Parkinson's disease	0.000184	0.00214	CbGeAlD
Desipramine—SLC22A5—cerebellum—Parkinson's disease	0.000183	0.00214	CbGeAlD
Desipramine—CYP2B6—head—Parkinson's disease	0.000178	0.00208	CbGeAlD
Desipramine—CHRM3—brain—Parkinson's disease	0.000178	0.00207	CbGeAlD
Desipramine—HTR1A—brain—Parkinson's disease	0.000177	0.00206	CbGeAlD
Desipramine—SLC6A2—brain—Parkinson's disease	0.000175	0.00204	CbGeAlD
Desipramine—HRH1—head—Parkinson's disease	0.000174	0.00203	CbGeAlD
Desipramine—Maprotiline—SLC6A3—Parkinson's disease	0.000173	0.0239	CrCbGaD
Desipramine—CYP2B6—nervous system—Parkinson's disease	0.000169	0.00197	CbGeAlD
Desipramine—HTR2A—midbrain—Parkinson's disease	0.000168	0.00195	CbGeAlD
Desipramine—CYP2E1—head—Parkinson's disease	0.000167	0.00195	CbGeAlD
Desipramine—ABCB1—forebrain—Parkinson's disease	0.000166	0.00194	CbGeAlD
Desipramine—HRH1—nervous system—Parkinson's disease	0.000165	0.00192	CbGeAlD
Desipramine—HTR2A—spinal cord—Parkinson's disease	0.000164	0.00191	CbGeAlD
Desipramine—CYP2B6—central nervous system—Parkinson's disease	0.000163	0.0019	CbGeAlD
Desipramine—DRD2—brain—Parkinson's disease	0.00016	0.00186	CbGeAlD
Desipramine—Triflupromazine—DRD1—Parkinson's disease	0.000159	0.022	CrCbGaD
Desipramine—HRH1—central nervous system—Parkinson's disease	0.000159	0.00185	CbGeAlD
Desipramine—CYP2E1—nervous system—Parkinson's disease	0.000159	0.00185	CbGeAlD
Desipramine—CYP2E1—central nervous system—Parkinson's disease	0.000153	0.00178	CbGeAlD
Desipramine—CYP2E1—cerebellum—Parkinson's disease	0.000149	0.00174	CbGeAlD
Desipramine—SLC22A5—brain—Parkinson's disease	0.000149	0.00173	CbGeAlD
Desipramine—Clomipramine—GSTP1—Parkinson's disease	0.000148	0.0205	CrCbGaD
Desipramine—Acepromazine—DRD1—Parkinson's disease	0.000147	0.0204	CrCbGaD
Desipramine—HTR2A—head—Parkinson's disease	0.000145	0.0017	CbGeAlD
Desipramine—Protriptyline—CYP2D6—Parkinson's disease	0.000142	0.0197	CrCbGaD
Desipramine—ABCB1—cardiovascular system—Parkinson's disease	0.000141	0.00164	CbGeAlD
Desipramine—Prochlorperazine—DRD3—Parkinson's disease	0.000138	0.0191	CrCbGaD
Desipramine—HTR2A—nervous system—Parkinson's disease	0.000138	0.00161	CbGeAlD
Desipramine—Mianserin—HTR7—Parkinson's disease	0.000133	0.0183	CrCbGaD
Desipramine—HTR2A—central nervous system—Parkinson's disease	0.000133	0.00155	CbGeAlD
Desipramine—CYP2D6—head—Parkinson's disease	0.000132	0.00154	CbGeAlD
Desipramine—HTR2A—cerebellum—Parkinson's disease	0.00013	0.00151	CbGeAlD
Desipramine—CYP2B6—brain—Parkinson's disease	0.000129	0.00151	CbGeAlD
Desipramine—Maprotiline—DRD2—Parkinson's disease	0.000129	0.0177	CrCbGaD
Desipramine—CYP3A4—nervous system—Parkinson's disease	0.000128	0.00149	CbGeAlD
Desipramine—HRH1—brain—Parkinson's disease	0.000126	0.00147	CbGeAlD
Desipramine—CYP2D6—nervous system—Parkinson's disease	0.000126	0.00146	CbGeAlD
Desipramine—Aprindine—CYP2D6—Parkinson's disease	0.000125	0.0173	CrCbGaD
Desipramine—Mianserin—DRD3—Parkinson's disease	0.000125	0.0172	CrCbGaD
Desipramine—CYP3A4—central nervous system—Parkinson's disease	0.000123	0.00143	CbGeAlD
Desipramine—Acepromazine—HTR1A—Parkinson's disease	0.000122	0.0169	CrCbGaD
Desipramine—CYP2E1—brain—Parkinson's disease	0.000121	0.00141	CbGeAlD
Desipramine—CYP2D6—central nervous system—Parkinson's disease	0.000121	0.00141	CbGeAlD
Desipramine—ABCB1—medulla oblongata—Parkinson's disease	0.00012	0.0014	CbGeAlD
Desipramine—Atomoxetine—SLC6A3—Parkinson's disease	0.000119	0.0164	CrCbGaD
Desipramine—CYP2D6—cerebellum—Parkinson's disease	0.000118	0.00138	CbGeAlD
Desipramine—Mianserin—SLC6A3—Parkinson's disease	0.000116	0.016	CrCbGaD
Desipramine—Epinastine—HTR2A—Parkinson's disease	0.000115	0.0159	CrCbGaD
Desipramine—Triflupromazine—DRD2—Parkinson's disease	0.000112	0.0155	CrCbGaD
Desipramine—ABCB1—midbrain—Parkinson's disease	0.00011	0.00128	CbGeAlD
Desipramine—ABCB1—spinal cord—Parkinson's disease	0.000107	0.00125	CbGeAlD
Desipramine—Epinastine—CYP2D6—Parkinson's disease	0.000106	0.0146	CrCbGaD
Desipramine—HTR2A—brain—Parkinson's disease	0.000105	0.00123	CbGeAlD
Desipramine—Acepromazine—DRD2—Parkinson's disease	0.000104	0.0144	CrCbGaD
Desipramine—Mianserin—HTR1A—Parkinson's disease	0.000102	0.0141	CrCbGaD
Desipramine—Protriptyline—ABCB1—Parkinson's disease	0.000102	0.014	CrCbGaD
Desipramine—Maprotiline—HTR2A—Parkinson's disease	9.93e-05	0.0137	CrCbGaD
Desipramine—Mequitazine—CYP2D6—Parkinson's disease	9.93e-05	0.0137	CrCbGaD
Desipramine—Trimipramine—SLC6A3—Parkinson's disease	9.78e-05	0.0135	CrCbGaD
Desipramine—CYP2D6—brain—Parkinson's disease	9.6e-05	0.00112	CbGeAlD
Desipramine—Prochlorperazine—DRD2—Parkinson's disease	9.55e-05	0.0132	CrCbGaD
Desipramine—ABCB1—head—Parkinson's disease	9.53e-05	0.00111	CbGeAlD
Desipramine—Nortriptyline—HTR1A—Parkinson's disease	9.1e-05	0.0126	CrCbGaD
Desipramine—Maprotiline—CYP2D6—Parkinson's disease	9.08e-05	0.0125	CrCbGaD
Desipramine—ABCB1—nervous system—Parkinson's disease	9.04e-05	0.00105	CbGeAlD
Desipramine—Promazine—DRD1—Parkinson's disease	8.73e-05	0.0121	CrCbGaD
Desipramine—ABCB1—central nervous system—Parkinson's disease	8.7e-05	0.00101	CbGeAlD
Desipramine—Mianserin—DRD2—Parkinson's disease	8.64e-05	0.0119	CrCbGaD
Desipramine—Trimipramine—HTR1A—Parkinson's disease	8.56e-05	0.0118	CrCbGaD
Desipramine—ABCB1—cerebellum—Parkinson's disease	8.5e-05	0.000991	CbGeAlD
Desipramine—Chlorpromazine—HTR7—Parkinson's disease	8.33e-05	0.0115	CrCbGaD
Desipramine—Imipramine—HTR7—Parkinson's disease	8.29e-05	0.0114	CrCbGaD
Desipramine—Amitriptyline—HTR7—Parkinson's disease	8.24e-05	0.0114	CrCbGaD
Desipramine—Doxepin—HTR1A—Parkinson's disease	8.16e-05	0.0113	CrCbGaD
Desipramine—Acepromazine—HTR2A—Parkinson's disease	8.03e-05	0.0111	CrCbGaD
Desipramine—Chlorpromazine—DRD3—Parkinson's disease	7.83e-05	0.0108	CrCbGaD
Desipramine—Amitriptyline—DRD3—Parkinson's disease	7.74e-05	0.0107	CrCbGaD
Desipramine—Nortriptyline—DRD2—Parkinson's disease	7.72e-05	0.0107	CrCbGaD
Desipramine—Chlorpromazine—DRD1—Parkinson's disease	7.69e-05	0.0106	CrCbGaD
Desipramine—Epinastine—ABCB1—Parkinson's disease	7.53e-05	0.0104	CrCbGaD
Desipramine—Nortriptyline—CYP2E1—Parkinson's disease	7.43e-05	0.0103	CrCbGaD
Desipramine—Trimipramine—DRD2—Parkinson's disease	7.27e-05	0.01	CrCbGaD
Desipramine—Imipramine—SLC6A3—Parkinson's disease	7.25e-05	0.01	CrCbGaD
Desipramine—Promethazine—DRD2—Parkinson's disease	7e-05	0.00966	CrCbGaD
Desipramine—Doxepin—DRD2—Parkinson's disease	6.93e-05	0.00957	CrCbGaD
Desipramine—ABCB1—brain—Parkinson's disease	6.91e-05	0.000805	CbGeAlD
Desipramine—Atomoxetine—HTR2A—Parkinson's disease	6.83e-05	0.00943	CrCbGaD
Desipramine—Prochlorperazine—CYP2D6—Parkinson's disease	6.75e-05	0.00932	CrCbGaD
Desipramine—Mianserin—HTR2A—Parkinson's disease	6.68e-05	0.00922	CrCbGaD
Desipramine—Maprotiline—ABCB1—Parkinson's disease	6.49e-05	0.00895	CrCbGaD
Desipramine—Chlorpromazine—HTR1A—Parkinson's disease	6.38e-05	0.00881	CrCbGaD
Desipramine—Imipramine—HTR1A—Parkinson's disease	6.35e-05	0.00877	CrCbGaD
Desipramine—Amitriptyline—HTR1A—Parkinson's disease	6.31e-05	0.00871	CrCbGaD
Desipramine—Atomoxetine—CYP2D6—Parkinson's disease	6.25e-05	0.00862	CrCbGaD
Desipramine—Promazine—DRD2—Parkinson's disease	6.16e-05	0.0085	CrCbGaD
Desipramine—Clomipramine—HTR2A—Parkinson's disease	6.11e-05	0.00843	CrCbGaD
Desipramine—Mianserin—CYP2D6—Parkinson's disease	6.1e-05	0.00843	CrCbGaD
Desipramine—Nortriptyline—HTR2A—Parkinson's disease	5.97e-05	0.00824	CrCbGaD
Desipramine—Triflupromazine—ABCB1—Parkinson's disease	5.67e-05	0.00783	CrCbGaD
Desipramine—Trimipramine—HTR2A—Parkinson's disease	5.62e-05	0.00776	CrCbGaD
Desipramine—Clomipramine—CYP2D6—Parkinson's disease	5.58e-05	0.00771	CrCbGaD
Desipramine—Nortriptyline—CYP2D6—Parkinson's disease	5.46e-05	0.00753	CrCbGaD
Desipramine—Chlorpromazine—DRD2—Parkinson's disease	5.42e-05	0.00748	CrCbGaD
Desipramine—Promethazine—HTR2A—Parkinson's disease	5.41e-05	0.00747	CrCbGaD
Desipramine—Imipramine—DRD2—Parkinson's disease	5.39e-05	0.00744	CrCbGaD
Desipramine—Amitriptyline—DRD2—Parkinson's disease	5.36e-05	0.0074	CrCbGaD
Desipramine—Doxepin—HTR2A—Parkinson's disease	5.35e-05	0.00739	CrCbGaD
Desipramine—Chlorpromazine—CYP2E1—Parkinson's disease	5.22e-05	0.0072	CrCbGaD
Desipramine—Imipramine—CYP2E1—Parkinson's disease	5.19e-05	0.00716	CrCbGaD
Desipramine—Amitriptyline—CYP2E1—Parkinson's disease	5.16e-05	0.00712	CrCbGaD
Desipramine—Trimipramine—CYP2D6—Parkinson's disease	5.14e-05	0.00709	CrCbGaD
Desipramine—Promethazine—CYP2D6—Parkinson's disease	4.95e-05	0.00683	CrCbGaD
Desipramine—Doxepin—CYP2D6—Parkinson's disease	4.9e-05	0.00676	CrCbGaD
Desipramine—Promazine—HTR2A—Parkinson's disease	4.76e-05	0.00657	CrCbGaD
Desipramine—Carbamazepine—ABCB1—Parkinson's disease	4.73e-05	0.00653	CrCbGaD
Desipramine—Chlorpromazine—HTR2A—Parkinson's disease	4.19e-05	0.00578	CrCbGaD
Desipramine—Imipramine—HTR2A—Parkinson's disease	4.17e-05	0.00575	CrCbGaD
Desipramine—Amitriptyline—HTR2A—Parkinson's disease	4.14e-05	0.00572	CrCbGaD
Desipramine—Clomipramine—ABCB1—Parkinson's disease	3.99e-05	0.0055	CrCbGaD
Desipramine—Chlorpromazine—CYP2D6—Parkinson's disease	3.83e-05	0.00529	CrCbGaD
Desipramine—Imipramine—CYP2D6—Parkinson's disease	3.81e-05	0.00526	CrCbGaD
Desipramine—Amitriptyline—CYP2D6—Parkinson's disease	3.79e-05	0.00523	CrCbGaD
Desipramine—Trimipramine—ABCB1—Parkinson's disease	3.67e-05	0.00506	CrCbGaD
Desipramine—Promethazine—ABCB1—Parkinson's disease	3.53e-05	0.00488	CrCbGaD
Desipramine—Doxepin—ABCB1—Parkinson's disease	3.5e-05	0.00483	CrCbGaD
Desipramine—Chlorpromazine—ABCB1—Parkinson's disease	2.73e-05	0.00378	CrCbGaD
Desipramine—Imipramine—ABCB1—Parkinson's disease	2.72e-05	0.00376	CrCbGaD
Desipramine—Amitriptyline—ABCB1—Parkinson's disease	2.7e-05	0.00373	CrCbGaD
Desipramine—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	5.76e-06	3.62e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	5.76e-06	3.62e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	5.74e-06	3.61e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	5.74e-06	3.61e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	5.74e-06	3.61e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	5.73e-06	3.6e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	5.68e-06	3.57e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	5.68e-06	3.57e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	5.68e-06	3.57e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—CYCS—Parkinson's disease	5.65e-06	3.55e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—GPX1—Parkinson's disease	5.63e-06	3.54e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	5.61e-06	3.53e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	5.61e-06	3.53e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—ABCB1—Parkinson's disease	5.59e-06	3.52e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	5.59e-06	3.51e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—MTHFR—Parkinson's disease	5.58e-06	3.51e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—APOE—Parkinson's disease	5.56e-06	3.5e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	5.55e-06	3.49e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—GPX1—Parkinson's disease	5.55e-06	3.49e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	5.49e-06	3.45e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—GSTM1—Parkinson's disease	5.43e-06	3.42e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	5.43e-06	3.41e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	5.4e-06	3.4e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	5.39e-06	3.39e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	5.36e-06	3.37e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—MAOB—Parkinson's disease	5.34e-06	3.36e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	5.34e-06	3.36e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—APOE—Parkinson's disease	5.32e-06	3.35e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—GPX1—Parkinson's disease	5.2e-06	3.27e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—MTHFR—Parkinson's disease	5.2e-06	3.27e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—APOE—Parkinson's disease	5.19e-06	3.26e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NGF—Parkinson's disease	5.15e-06	3.24e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—MTHFR—Parkinson's disease	5.12e-06	3.22e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—COMT—Parkinson's disease	5.11e-06	3.21e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	5.09e-06	3.2e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—GSTP1—Parkinson's disease	5.08e-06	3.2e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.08e-06	3.2e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—MAOA—Parkinson's disease	5.07e-06	3.19e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NGF—Parkinson's disease	5.04e-06	3.17e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—HMOX1—Parkinson's disease	5.01e-06	3.15e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—COMT—Parkinson's disease	5e-06	3.15e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CTGF—Parkinson's disease	5e-06	3.14e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—GSTP1—Parkinson's disease	4.98e-06	3.13e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	4.97e-06	3.13e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—MAOA—Parkinson's disease	4.97e-06	3.12e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	4.93e-06	3.1e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NGF—Parkinson's disease	4.93e-06	3.1e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—HMOX1—Parkinson's disease	4.91e-06	3.09e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	4.91e-06	3.09e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	4.9e-06	3.08e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—DDC—Parkinson's disease	4.9e-06	3.08e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CTGF—Parkinson's disease	4.88e-06	3.07e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	4.85e-06	3.05e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	4.84e-06	3.04e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—APOE—Parkinson's disease	4.84e-06	3.04e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	4.82e-06	3.03e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—ABCB1—Parkinson's disease	4.81e-06	3.03e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	4.81e-06	3.02e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—MTHFR—Parkinson's disease	4.8e-06	3.02e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	4.8e-06	3.02e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	4.77e-06	3e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—APOE—Parkinson's disease	4.76e-06	3e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	4.76e-06	3e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—INS—Parkinson's disease	4.75e-06	2.99e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—ABCB1—Parkinson's disease	4.71e-06	2.96e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	4.71e-06	2.96e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	4.69e-06	2.95e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	4.69e-06	2.95e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	4.68e-06	2.94e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—GSTM1—Parkinson's disease	4.67e-06	2.94e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	4.67e-06	2.94e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	4.66e-06	2.93e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	4.66e-06	2.93e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	4.65e-06	2.92e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	4.63e-06	2.91e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	4.62e-06	2.91e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	4.62e-06	2.91e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	4.61e-06	2.9e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—NQO1—Parkinson's disease	4.61e-06	2.9e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	4.6e-06	2.9e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CTGF—Parkinson's disease	4.6e-06	2.89e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	4.59e-06	2.89e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—GSTM1—Parkinson's disease	4.58e-06	2.88e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—APOE—Parkinson's disease	4.56e-06	2.87e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	4.55e-06	2.86e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—INS—Parkinson's disease	4.55e-06	2.86e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	4.55e-06	2.86e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—TH—Parkinson's disease	4.54e-06	2.86e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—NQO1—Parkinson's disease	4.5e-06	2.83e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—GPX1—Parkinson's disease	4.47e-06	2.81e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—APOE—Parkinson's disease	4.47e-06	2.81e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—APOE—Parkinson's disease	4.46e-06	2.81e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—INS—Parkinson's disease	4.43e-06	2.79e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—TH—Parkinson's disease	4.43e-06	2.79e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—GPX1—Parkinson's disease	4.38e-06	2.76e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—APOE—Parkinson's disease	4.36e-06	2.74e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CYCS—Parkinson's disease	4.36e-06	2.74e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	4.34e-06	2.73e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NGF—Parkinson's disease	4.33e-06	2.72e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	4.29e-06	2.7e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	4.26e-06	2.68e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CYCS—Parkinson's disease	4.25e-06	2.68e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NGF—Parkinson's disease	4.25e-06	2.67e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—NQO1—Parkinson's disease	4.24e-06	2.66e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	4.24e-06	2.66e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NGF—Parkinson's disease	4.22e-06	2.66e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	4.18e-06	2.63e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—TH—Parkinson's disease	4.18e-06	2.63e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	4.16e-06	2.62e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—INS—Parkinson's disease	4.13e-06	2.6e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—MTHFR—Parkinson's disease	4.13e-06	2.6e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.12e-06	2.59e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	4.12e-06	2.59e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—INS—Parkinson's disease	4.07e-06	2.56e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	4.05e-06	2.54e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—MTHFR—Parkinson's disease	4.04e-06	2.54e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	4.03e-06	2.54e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	4.02e-06	2.53e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CYCS—Parkinson's disease	4.01e-06	2.52e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	3.98e-06	2.5e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	3.97e-06	2.5e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—INS—Parkinson's disease	3.9e-06	2.45e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CTGF—Parkinson's disease	3.9e-06	2.45e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—COMT—Parkinson's disease	3.86e-06	2.43e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—APOE—Parkinson's disease	3.84e-06	2.42e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	3.84e-06	2.42e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—MAOA—Parkinson's disease	3.83e-06	2.41e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—APOE—Parkinson's disease	3.83e-06	2.41e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—INS—Parkinson's disease	3.82e-06	2.4e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—INS—Parkinson's disease	3.81e-06	2.4e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	3.79e-06	2.38e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	3.77e-06	2.37e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—COMT—Parkinson's disease	3.77e-06	2.37e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—APOE—Parkinson's disease	3.77e-06	2.37e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—APOE—Parkinson's disease	3.76e-06	2.37e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—GSTP1—Parkinson's disease	3.75e-06	2.36e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	3.75e-06	2.36e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—MAOA—Parkinson's disease	3.74e-06	2.35e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—APOE—Parkinson's disease	3.74e-06	2.35e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—INS—Parkinson's disease	3.73e-06	2.34e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—INS—Parkinson's disease	3.71e-06	2.33e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	3.7e-06	2.33e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—HMOX1—Parkinson's disease	3.7e-06	2.33e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	3.64e-06	2.29e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	3.63e-06	2.28e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—NQO1—Parkinson's disease	3.59e-06	2.26e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—COMT—Parkinson's disease	3.55e-06	2.23e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—TH—Parkinson's disease	3.54e-06	2.22e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	3.54e-06	2.22e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	3.53e-06	2.22e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	3.53e-06	2.22e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—MAOA—Parkinson's disease	3.53e-06	2.22e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	3.51e-06	2.21e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	3.49e-06	2.19e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—GSTM1—Parkinson's disease	3.45e-06	2.17e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CYCS—Parkinson's disease	3.4e-06	2.14e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	3.39e-06	2.13e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—GPX1—Parkinson's disease	3.38e-06	2.13e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	3.36e-06	2.12e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	3.35e-06	2.1e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—GPX1—Parkinson's disease	3.3e-06	2.08e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—INS—Parkinson's disease	3.28e-06	2.07e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—INS—Parkinson's disease	3.27e-06	2.06e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	3.25e-06	2.04e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	3.25e-06	2.04e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—INS—Parkinson's disease	3.22e-06	2.02e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—INS—Parkinson's disease	3.22e-06	2.02e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—INS—Parkinson's disease	3.21e-06	2.02e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—INS—Parkinson's disease	3.2e-06	2.01e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—INS—Parkinson's disease	3.19e-06	2.01e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—INS—Parkinson's disease	3.16e-06	1.99e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	3.12e-06	1.96e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	3.11e-06	1.96e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GPX1—Parkinson's disease	3.11e-06	1.96e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	3.06e-06	1.93e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—MTHFR—Parkinson's disease	3.05e-06	1.92e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—COMT—Parkinson's disease	3.01e-06	1.89e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.01e-06	1.89e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	2.99e-06	1.88e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—MAOA—Parkinson's disease	2.99e-06	1.88e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	2.95e-06	1.86e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—APOE—Parkinson's disease	2.91e-06	1.83e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	2.9e-06	1.82e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	2.88e-06	1.81e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	2.87e-06	1.81e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	2.84e-06	1.78e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—APOE—Parkinson's disease	2.84e-06	1.78e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	2.83e-06	1.78e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	2.82e-06	1.77e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.8e-06	1.76e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	2.77e-06	1.75e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.77e-06	1.74e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	2.76e-06	1.74e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	2.76e-06	1.73e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	2.75e-06	1.73e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	2.74e-06	1.72e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—TH—Parkinson's disease	2.73e-06	1.72e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—APOE—Parkinson's disease	2.67e-06	1.68e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	2.67e-06	1.68e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GPX1—Parkinson's disease	2.63e-06	1.66e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.62e-06	1.65e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	2.61e-06	1.64e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	2.55e-06	1.6e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	2.54e-06	1.6e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—INS—Parkinson's disease	2.48e-06	1.56e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	2.44e-06	1.53e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	2.43e-06	1.53e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—INS—Parkinson's disease	2.42e-06	1.52e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	2.42e-06	1.52e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	2.4e-06	1.51e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	2.39e-06	1.5e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	2.38e-06	1.5e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	2.38e-06	1.5e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	2.38e-06	1.49e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	2.38e-06	1.49e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	2.37e-06	1.49e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	2.36e-06	1.49e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	2.35e-06	1.48e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	2.34e-06	1.47e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—COMT—Parkinson's disease	2.32e-06	1.46e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.31e-06	1.45e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.31e-06	1.45e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—INS—Parkinson's disease	2.28e-06	1.44e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.28e-06	1.43e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—APOE—Parkinson's disease	2.26e-06	1.42e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	2.24e-06	1.41e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	2.2e-06	1.39e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	2.2e-06	1.38e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	2.19e-06	1.38e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.19e-06	1.38e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	2.18e-06	1.37e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	2.16e-06	1.36e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.12e-06	1.34e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—Parkinson's disease	2.08e-06	1.31e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.03e-06	1.28e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—Parkinson's disease	1.99e-06	1.25e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—INS—Parkinson's disease	1.93e-06	1.22e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.88e-06	1.18e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—APOE—Parkinson's disease	1.75e-06	1.1e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—Parkinson's disease	1.7e-06	1.07e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—Parkinson's disease	1.67e-06	1.05e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.63e-06	1.02e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.62e-06	1.02e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—INS—Parkinson's disease	1.49e-06	9.39e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.43e-06	8.99e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.41e-06	8.85e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.4e-06	8.83e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	1.4e-06	8.8e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—Parkinson's disease	1.39e-06	8.77e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	1.38e-06	8.69e-06	CbGpPWpGaD
